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ABSTRACT
Macrophages are components of the innate immune system with key
roles in tissue inflammation and repair. It is now evident that
macrophages also support organogenesis, but few studies have
characterized their identity, ontogeny and function during heart
development. Here, we show that the distribution and prevalence of
resident macrophages in the subepicardial compartment of the
developing heart coincides with the emergence of new lymphatics, and
that macrophages interact closely with the nascent lymphatic capillaries.
Consequently, global macrophage deficiency led to extensive vessel
disruption, with mutant hearts exhibiting shortened and mis-patterned
lymphatics. The origin of cardiac macrophages was linked to the yolk
sac and foetal liver. Moreover, the Cx3cr1+ myeloid lineage was found
to play essential functions in the remodelling of the lymphatic
endothelium. Mechanistically, macrophage hyaluronan was required
for lymphatic sprouting by mediating direct macrophage-lymphatic
endothelial cell interactions. Together, these findings reveal insight into
the role of macrophages as indispensable mediators of lymphatic
growth during the development of the mammalian cardiac vasculature.
KEY WORDS: Macrophages, Hyaluronan, Cell adhesion, Cardiac
lymphatics, Coronaries, Vessel growth and patterning
INTRODUCTION
The cardiac vasculature, composed of the coronary circulation and
lymphatic vessel network, begins to develop from around mid-
gestation, at approximately embryonic day (E)11.5 in the mouse.
Lymphatic endothelial cells (LECs) expressing the canonical
lymphatic prospero homeobox 1 transcription factor (PROX1),
vascular endothelial growth factor receptor 3 (VEGFR3) and
lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1), first
arise in the vicinity of the sinus venosus (dorsal side) and outflow
tract (ventral side) of the murine heart at∼E12.5 (Klotz et al., 2015).
LECs then assemble into a primitive plexus that expands and
remodels prenatally in the sub-epicardial layer along the base-to-
apex axis and postnatally towards the myocardium, to form an
extensive lymphatic system that drains lymph from the heart to
enable optimal cardiac function (Flaht-Zabost et al., 2014; Klotz
et al., 2015). Defects in lymphatic drainage are associated with heart
disease, where an increase in tissue fluid content by as little as 2.5%
can lead to a 30-40% reduction in cardiac output (Dongaonkar et al.,
2010; Laine and Allen, 1991). Conversely, cardiac lymphatics
respond to myocardial infarction by re-activating a lymphangiogenic
gene expression programme; therapeutic stimulation of this process
enhances resolution of macrophage-driven inflammation, promoting
tissue repair (Klotz et al., 2015; Vieira et al., 2018). Together, these
findings emphasize the importance of the cardiac lymphatic system
and the need for a better understanding of the cellular and molecular
mechanisms underlying its development.
The ontogeny of LECs integrating within the heart and other
organ-based lymphatics has been the focus of a paradigm shift in
recent times, with non-venous endothelial precursors now accepted
as an additional source of the lineage (Eng et al., 2019; Gancz et al.,
2019; Klotz et al., 2015; Martinez-Corral et al., 2015; Stanczuk
et al., 2015; Stone and Stainier, 2019; Ulvmar and Mäkinen, 2016).
The precise identity and origin of these non-venous LEC precursors
remains somewhat elusive, although genetic lineage-tracing
experiments have implicated the Tie2/PDGFB-negative transient
embryonic haemogenic endothelium of the yolk sac and, more
recently, second heart field-derived progenitors as contributing to
cardiac lymphangiogenesis (Klotz et al., 2015; Lioux et al., 2020;
Maruyama et al., 2019).
Macrophages are myeloid immune cells strategically dispersed
throughout the tissues of the body. They have a vast functional
repertoire and emerging plasticity that converges on normal
homeostasis and responses to pathology, through mediating
inflammation and repair. Macrophages were initially described in
sites of physiological cell death within the bulbus cordis of
embryonic chick and rat hearts, using light and electron microscopy
(Manasek, 1969; Pexieder, 1975; Sorokin et al., 1994).
Subsequently, in vitro experiments confirmed macrophages as
phagocytic cells and, therefore, it was hypothesized that their
primary role was to remove debris arising from cell death (Sorokin
et al., 1994). Indeed, macrophages are specialized phagocytes with a
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classical role in engulfing and digesting dying or dead cells, cellular
debris and pathogens. Macrophages are also responsible for
cytokine production, and act as a source of pro (lymph-
)angiogenic factors, such as VEGFA, VEGFC and VEGFD,
which in turn support tumour growth, vascularization and
dissemination (Qian and Pollard, 2010). In addition to these
classical roles in postnatal settings, macrophages have been
implicated more recently in organogenesis during embryonic
development and tissue regeneration after injury (Aurora et al.,
2014; Theret et al., 2019), as well as in the maintenance of arterial
tone through regulation of collagen turnover (Lim et al., 2018). In
the embryo, macrophages arise initially from the extra-embryonic
transient yolk sac and subsequently from alternative sources within
the embryo proper, including foetal liver-resident erythro-myeloid
progenitors (EMPs) and hematopoietic stem cells (HSCs) (Ginhoux
and Guilliams, 2016). Yolk sac-derived macrophages seed most
tissue-resident niches, which are maintained through adulthood by
self-renewal (e.g. microglia in the brain) or gradually replenished by
foetal liver EMP-derived monocytes, with both populations having
distinct roles in tissue injury responses (Hoeffel et al., 2015; Lavine
et al., 2014; Stremmel et al., 2018). In the developing heart, the
outer mesothelial layer, the epicardium, has been proposed as an
important signalling axis to recruit primitive yolk sac-derived
macrophages to the subepicardial space (Stevens et al., 2016). The
reported timescale for embryonic macrophage recruitment coincides
with major morphological changes taking place in the forming
heart, i.e. chamber septation, endocardial cushion formation and
valve remodelling, myocardial growth and maturation, development
of the electrical conduction system, and the emergence and
expansion of the coronary and lymphatic vasculature. As such,
tissue-resident macrophages have been considered as potential key
contributors to some of these processes via their functional roles in
engulfing dying cells, releasing soluble cytokines, interacting with
or recruiting progenitor cells and their potential to transdifferentiate
into alternative cell types. Although a functional requirement has
been identified for cardiac macrophages in valvular remodelling,
normal conduction and coronary development (Hulsmans et al., 2017;
Leid et al., 2016; Shigeta et al., 2019), there have been no reported
roles during cardiac lymphatic development to date. Given that
macrophages contribute to adult lymphangiogenesis within
inflammatory, wound healing and tumour microenvironmental
settings (Qian and Pollard, 2010; Ran and Montgomery, 2012), as
well as in the developing skin (where they define nascent vessel
calibre) (Gordon et al., 2010), we sought to investigate the role of
tissue-resident macrophages in the developing heart. Here, we
demonstrate for the first time that macrophages are essential for
cardiac lymphatic growth and remodelling. Macrophages colonized
the embryonic heart prior to the initiation of lymphatic expansion,
closely associating and interacting with the adventitial surface and
leading edges of lymphatic vessels, where they promoted growth and
fusion to ensure an adequate coverage over the subepicardial surface.
Global genetic ablation of myeloid cells led to hyperplastic and
shortened lymphatic vessels in the heart, which failed to branch
properly, and to a mis-patterning of the coronary blood vessels. Both
extra- and intra-embryonic hematopoietic sources were found to
contribute to the tissue-resident macrophage population, and fate
mapping, based on canonical myeloid CSF1R and CX3CR1 markers,
identified overlapping lineages that contributed to the remodelling of
the nascent lymphatic network. In a co-culture model of human
lymphatic endothelial cells with human induced pluripotent stem
cell-derived macrophages (hiPSC-macrophages), the latter closely
associated with tube-forming lymphatic endothelium, where they
induced sprouting, replicating our in vivo findings. Mechanistically, a
direct interaction between LECs and hiPSCmacrophages was found to
be dependent on macrophage hyaluronan, a linear glycosaminoglycan
composed of a repeating disaccharide unit of D-glucuronic acid and N-
acetyl-D-glucosamine, previously implicated in cell motility and
adhesion during angiogenesis, and in leukocyte trafficking through the
lymph, respectively (Jackson, 2019; Johnson et al., 2017; Lim et al.,
2018; Savani et al., 2001). These findings significantly increase our
knowledge of (lymphatic) vascular biology and provide further insight
into the plasticity and diversity of tissue-resident macrophage function
during development. Mechanistic insight into the cellular interactions
controlling lymphatic vessel formation is potentially of more
widespread interest in terms of understanding how to therapeutically
modulate macrophages and lymphatic growth during heart disease.
RESULTS
Tissue-resident macrophages are closely associated with
developing cardiac lymphatics
To investigate the earliest timepoint at whichmacrophages were first
detected in the developing heart, we initially analysed published
single-cell RNA sequencing (scRNA-seq) data from whole heart at
E9.25 and E10.5 (de Soysa et al., 2019; Hill et al., 2019) (Fig. S1).
Although no macrophage cluster was detected at E9.25 (de Soysa
et al., 2019), graph-based clustering followed by dimensionality
reduction using uniform manifold approximation and projection
(UMAP) (Becht et al., 2018) of the E10.5 dataset revealed 18
clusters corresponding to the major cardiac cell types [i.e.
cardiomyocytes (CMs), endocardial cells (Endo), mesenchymal
cells (Mes), epicardial cells (Epi) and second heart field cardiac
progenitor cells (SHF)], which also included resident macrophages
(Fig. S1A). The identity of the macrophage cluster was defined by
the expression of key myeloid markers, including receptors for the
chemokine fractalkine (Cx3cr1) and cytokine colony-stimulating
factor 1 (Csf1r) (Fig. S1B). Expression of the chemotactic ligand
Csf1 was detected exclusively in the Epi cluster, supporting the
hypothesis that epicardial signalling underlies cardiac colonization
and seeding of myeloid cells in the subepicardial compartment
(Fig. S1B) (Stevens et al., 2016). To validate these findings, we
made use of the Cx3cr1-GFP reporter mouse, which expresses
enhanced GFP under the control of the endogenous Cx3cr1 locus
(Jung et al., 2000). We found that GFP+ myeloid cells were present
in the developing heart at E10.5 ahead of the onset of coronary and
lymphatic vessel growth, being located on the sinus venosus and
outer surface of the adjacent ventricular wall (Fig. S1C). Next, to
assess a possible role in the formation of the cardiac lymphatic
system, we measured the numbers and spatial distribution of tissue-
resident macrophages in heart specimens at E12.5 and beyond
(Fig. 1). Specifically, flow cytometric analysis of Cx3cr1GFP/+
foetal hearts at E12.5, E14.5 and E16.5 combined with staining for
the canonical macrophage marker EGF-like module-containing
mucin-like hormone receptor-like 1 (EMR1; henceforth, known as
F4/80) (Hume and Gordon, 1983) revealed a distinct population of
live singlet cells expressing both markers (Fig. 1A). Moreover, the
proportion of GFP+F4/80+ macrophages over the total number of
live singlet cells increased gradually from 0.39±0.06 at E12.5 to
0.70±0.05 at E14.5 and 0.83±0.02 at E16.5 (E12.5 versus E14.5,
P<0.01; E12.5 versus E16.5, P<0.001; E14.5 versus E16.5, P<0.05;
Fig. 1A), suggesting active recruitment and/or proliferation of
macrophages throughout the time-course of cardiac development.
To further characterize the macrophage population residing in the
developing heart of Cx3cr1GFP/+mice, we performed whole-mount
immunofluorescence staining using antibodies against the widely
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expressed vascular marker endomucin [EMCN; restricted to
capillaries and veins from E15.5 onwards (Brachtendorf et al.,
2001)] and the lymphatic marker LYVE1, which is also expressed in
macrophages (Klotz et al., 2015; Lim et al., 2018) (Fig. 1B-M). At
E12.5, GFP+ macrophages were found proximal to the sinus
venosus (Fig. 1B,C) and in the outflow tract (Fig. 1D,E), prior to the
onset of coronary and cardiac lymphatic vessel formation (Chen
et al., 2014; Klotz et al., 2015). Indeed, only a primitive EMCN+
Fig. 1. Tissue-resident macrophages are closely associated with the developing cardiac lymphatics. (A) Representative histograms and percentage of
tissue-resident macrophages over total number of live singlet cells in the developing heart at embryonic days (E) 12.5, E14.5 and E16.5 measured by flow
cytometry for GFP and F4/80 inCx3cr1GFP/+ reporter embryos. GFP+F4/80+ cells are defined asmacrophages. Data are mean±s.e.m.; n=6 hearts per group from
at least three independent litters. Significant differences (P-values) were calculated using one-way ANOVA followed by Tukey’s multiple comparison test
(*P≤0.05; **P≤0.01; ****P≤0.0001). (B-M) Whole-mount immunostaining for GFP (green), LYVE1 (red) and EMCN (white) to visualize the sub-epicardial
tissue-resident macrophages, coronary vessels (capillaries and veins) and lymphatic plexus (respectively) in both the dorsal and ventral aspects of hearts derived
from Cx3cr1GFP/+ embryos at E12.5 (B-E), E14.5 (F-I) and E16.5 (J-M). (C,E,G,I,K,M) Magnified views of boxes shown in B,D,F,H,J,L. LYVE1 reactivity is
detected in the lymphatic endothelium and tissue-resident macrophages. (N-Q) GFP (green) and VEGFR3 (red) immunostaining of whole-mount hearts derived
from CD68-GFP-expressing embryos at E16.5. (Q) Orthogonal view of the box shown in P; white arrowheads indicate close association of CD68-GFP+
macrophages with VEGFR3-expressing lymphatic vessels. (R-U) LYVE1 (green) and PROX1 (red) immunostaining of whole-mount hearts derived from
C57BL6 embryos at E16.5. (U) Orthogonal view of the box shown in T; white arrowheads indicate LYVE1+ macrophages interacting with fusing lymphatic tip cells
labelled with PROX1 (nuclear) and LYVE1 (membrane). n=3-6 hearts per group from at least three independent litters. Scale bars: 100 µm in B-N; 25 µm in Q;
200 µm in R; 50 µm in U.
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capillary network and GFP+LYVE-1+ macrophages, but no LYVE-
1+ lymphatics, were evident in the subepicardial space at this stage
(Fig. 1B-E). At E14.5, GFP+LYVE-1+ macrophages were more
broadly dispersed in both dorsal and ventral surfaces of the
developing heart and, in regions covered by vessels, macrophages
were found to be in close proximity to, or in direct contact with, the
nascent EMCN+ coronary and LYVE-1+ lymphatic vasculature
(compare Fig. 1F,G with Fig. 1H,I). By E16.5, this spatial pattern of
distribution was even more evident, with GFP+LYVE-1+
subepicardial macrophages associating with the contiguous patent
coronary and lymphatic networks (dorsal and ventral sides), notably
alongside vessel branch junctions, leading ends (i.e. tips) and
adventitial surface of vessel walls (Fig. 1J-M). Tissue-resident
macrophages have previously been implicated in coronary vessel
development and maturation (Leid et al., 2016), but their role in
cardiac lymphatic vessel growth and remodelling remains
undetermined. To investigate this further, we initially validated
the findings in Cx3cr1GFP/+ mice, by investigating the developing
cardiac lymphatics in transgenic hCD68-GFP mice, which report
enhanced GFP in macrophages under the control of the human
CD68 promoter and enhancer sequences (Iqbal et al., 2014), and in
wild-type mice combined with VEGFR3, LYVE-1 or PROX1
markers at E16.5 (Fig. 1N-U). Macrophages were found to be
colocalized in the subepicardial space with VEGFR3+ lymphatic
vessels, and were intimately associated with vessel branching and
the leading edges of vessel sprouts (Fig. 1Q, white arrowheads and
orthogonal views). Moreover, macrophages were detected bridging
adjacent PROX1+ lymphatic tips potentially to promote vessel
fusion (Fig. 1U, white arrowheads), analogous to the previously
reported cellular chaperone role for tissue-resident macrophages
during blood vessel expansion in the developing hindbrain and
postnatal retina (Fantin et al., 2010). Taken together, these studies
reveal that tissue-resident macrophages colonize the embryonic
heart prior to the formation of the main vascular networks and adopt
a spatial distribution in close proximity to, and in contact with, the
forming lymphatics.
Yolk sac-derived myeloid cells associate with lymphatic
expansion
To define the origins of macrophages colonizing the developing
heart during lymphatic vessel development, we employed genetic
lineage tracing using Csf1r-, Cx3cr1- and Flt3-based mouse
models, which in combination capture the main hematopoietic
sources from early to mid-gestation, i.e. the yolk sac (Csf1r and
Cx3Cr1) and foetal liver (Flt3) (Benz et al., 2008; Ginhoux and
Guilliams, 2016; Gomez Perdiguero et al., 2015; Kasaai et al., 2017;
Stremmel et al., 2018) (Fig. 2). We initially employed theCsf1r-Mer-
iCre-Mer transgenic model (henceforth referred to as, Csf1r-CreER
mice) (Qian et al., 2011) crossed with R26R-tdTomato reporter mice
in which CRE recombinase activity downstream of the Csf1r
promoter sequence was induced by tamoxifen pulsing at E8.5
(Fig. 2A-D). This phased induction ensured mapping of the
spatiotemporal pattern of Csf1r activity in the transient yolk sac-
derived EMP compartment (Gomez Perdiguero et al., 2015; Hoeffel
et al., 2015). At E16.5, Csf1r-CreER+ hearts pulsed at E8.5 revealed
tdTomato+ cells in close proximity to, or in direct contact with,
PROX1-expressing LECs, with some of these cells exhibiting dual
expression of tdTomato and PROX1 (Fig. 2B, white arrowhead). Of
note, this modest, but reproducible contribution of the Csf1r+ lineage
to lymphatic endothelium (see also Klotz et al., 2015), supports the
hypothesis that a subset of CSF1R+ EMPs colonizing the developing
heart may give rise to LECs that integrate the nascent vasculature,
contributing to the reported endothelial heterogeneity (Klotz et al.,
2015; Lioux et al., 2020;Maruyama et al., 2019). Recently, a yolk sac-
derived CSF1R+ EMP population was reported to contribute
extensively to the endothelium of the nascent vasculature of the
developing hindbrain (Plein et al., 2018). However, unlike in the
brain, yolk sac-derived CSF1R+ EMPs colonizing the heart appear to
give rise mostly to tissue-resident macrophages seeding the
subepicardial compartment prior to the onset of lymphatic
expansion, i.e. E12.5 (Fig. S2A-D).
To more specifically characterize the ontogeny of cardiac
macrophages, given the broader lineage labelling achieved with
Fig. 2. Yolk sac-derived Csf1r+ and Cx3cr1+ lineages are associated with cardiac lymphatic growth and expansion. (A-D) Genetic lineage-tracing based
on the activity of the Csf1r-CreER;tdTomato transgene induced by tamoxifen administration at embryonic day (E) 8.5. Whole hearts were analysed for Tomato
(red) and PROX1 (green) expression at E16.5. (B-D) Magnified views of the box shown in A; white arrowhead indicates colocalization of native Tomato and
PROX1 immunoreactivity. (E-H) Genetic lineage-tracing based on the activity of the Cx3cr1CreER/+;tdTomato transgene induced by tamoxifen administration at
E8.5. Whole hearts were analyzed for Tomato (red) and PROX1 (green) expression at E16.5. (F-H) Magnified views of the box shown in E. (I-L) Genetic lineage-
tracing based on the activity of the Flt3CreERT2/+;tdTomato transgene induced by repeated tamoxifen administration at E13.5 and E15.5. Whole hearts were
analyzed for Tomato (red) and PROX1 (green) expression at E16.5. (J-L) Magnified views of the box shown in I. n=3-6 hearts per group from at least three
independent litters. Scale bars: 100 µm.
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the Csf1r-CreERmodel (i.e. EMPs, EMP-derived macrophages and
EMP-derived LECs), we analysed the hearts of Cx3cr1CreER/+;
tdTomato+ embryos, pulsed with tamoxifen at E8.5 (Fig. 2E-H).
The Cx3cr1CreER mouse drives expression of the fusion protein
CRE-ERT2 (Cre recombinase-oestrogen receptor) under the control
of the endogenous myeloid-specific Cx3cr1 locus (Parkhurst et al.,
2013) and hence, tamoxifen pulse-chase from E8.5 was anticipated
to capture the involvement of yolk sac-derived pre-macrophages
(Ginhoux and Guilliams, 2016; Stremmel et al., 2018). Using this
approach, we observed widespread contribution from extra-
embryonic hematopoietic compartments (i.e. yolk sac) to the
macrophage population residing in the developing heart and closely
associated with the nascent PROX1+ lymphatic network. Of note,
tamoxifen pulsing at E8.5 led to labelling (tdTomato+) of 60.5%±
4.29% of total LYVE1+ resident macrophages in the developing
heart (Fig. S2E-H; n=5 hearts). Moreover, we did not observe any
direct contribution of the Cx3cr1+ lineage to LECs within the
forming lymphatic plexus, confirming its myeloid cell specificity
(compare Fig. 2E-H with Fig. 2A-D).
To investigate a potential contribution from intra-embryonic
definitive HSCs to the tissue-resident macrophage population in the
developing heart, we used the Flt3CreERT2mouse model (Benz et al.,
2008). Upregulation of FMS-like tyrosine kinase 3 (FLT3; also
known as foetal liver kinase 2 or FLK2) is accompanied by loss of
self-renewal of definitive HSCs and Cre recombinase-driven by the
Flt3 locus has been demonstrated to label all progeny arising from
HSCs, including myeloid cells (Boyer et al., 2011). At E16.5,
Flt3CreERT2/+ hearts pulsed at E13.5 and E15.5 to maximize
recombination efficiency driven by the onset of Flt3 expression
resulted in tdTomato+ cells residing in close proximity to, or in
direct contact with, PROX1+ lymphatic vessels on the subepicardial
surface (Fig. 2I-L), indicating cell contribution from the definitive
HSC compartment in the foetal liver to the heart at later stages of
foetal development when lymphatic expansion is already well-
established. Again, as for the Cx3cr1+ lineage, no direct
contribution to cardiac lymphatic endothelium was observed.
However, closer examination of the Flt3+ derivatives resident in
the heart at E16.5 by immunostaining revealed that these cells
lacked the expression of LYVE-1, raising questions about their
identity (Fig. S2M-P).
Macrophages are required for growth and branching of the
cardiac lymphatic network
Our data suggest that yolk sac-derived myeloid lineages, defined by
the activity of Csf1r and Cx3cr1 gene expression, migrate to the
heart and give rise to macrophages that seed the outer surface of the
ventricular wall and interact closely with the neighbouring
lymphatic vessel network that develops from E12.5 onwards. To
determine the functional requirements for these tissue-resident
macrophages, we first investigated cardiac lymphatic development
in a mouse model deficient for the essential ETS domain-containing
transcription factor PU.1 (Fig. 3). Pu.1 (also known as Spi1)
knockout mice die around birth due to a severely underdeveloped
immune system, including a lack of myeloid cells (McKercher et al.,
1996; Scott et al., 1994). The number of myeloid cells and
macrophages in the developing hearts of Pu.1-null mice was
determined by flow cytometry for the expression of the pan-
leukocyte CD45, myeloid CD11b and macrophage F4/80 markers,
and found to be significantly reduced compared with control
littermate embryos (CD45+CD11b+ myeloid cells: 1.35±0.25%
versus 0.02±0.008% of all live cells, P<0.01; CD45+CD11b+F4/
80+ macrophages: 85.4±2.77% versus 0.0±0.0% of all live cells,
P<0.0001; Fig. S3A-D). As a consequence, cardiac lymphatic
growth and patterning was observed to be severely disrupted in
Pu.1−/− compared with control littermates at E16.5, with mutant
hearts exhibiting hyperplastic and shortened LYVE-1+ vessels
(vessel length: 12,536±1155 µm versus 7231±734.8 µm; P<0.01),
as well as a significant reduction in the number of junctions (i.e.
branchpoints; control 254.2±32.77 versus Pu.1−/− 104.0±10.52;
P<0.01) and overall plexus complexity; indicative of a sprouting/
branching defect (Fig. 3A-J). A similar phenotype was observed at
E19.5, before the onset of embryo demise at perinatal stages
(Fig. 3K-T). Embryo size and heart morphology in Pu.1-deficient
specimens appeared grossly normal, with no evident defects in heart
growth, cardiac septation or compaction of the myocardial layer
(Fig. S3E,F), hence ruling out the possibility of a secondary cardiac
phenotype contributing to the observed lymphatic defects.
However, coronary blood vessel growth and patterning were also
affected, with null hearts displaying an overall reduction in
subepicardial capillary vessel length and junction number
(Fig. 4A-J), as well as exhibiting extra branches of main EMCN+
coronary veins (Fig. 4E, white asterisk) compared with control
littermates at E16.5. The mis-patterning of EMCN+ coronary veins
was still evident in Pu.1-deficient hearts at E19.5 (Fig. 4K-R, white
asterisks in O and Q), whereas the coronary capillary vessel length
and junction density were restored to levels equivalent to those in
control littermate hearts (Fig. 4S,T).
In a previous study, macrophages in the skin were shown to define
dermal vessel calibre by regulating lymphatic endothelial cell
proliferation (Gordon et al., 2010). However, we did not observe
any gross changes in LEC proliferation in Pu.1-null hearts compared
with control littermates at E16.5 (Fig. S3G-N), suggesting inherent
differences across organ-specific lymphatic beds. The latter is
supported by the emerging recognition of heterogeneity across the
lymphatic vascular system and the existence of distinct origins for
subpopulations of LECs (Ulvmar and Mäkinen, 2016).
To specifically confirm a functional role for yolk sac-derived
macrophages in cardiac lymphatic development and to exclude
confounding factors arising from the indiscriminate targeting of
immune cell development and potentially contributing to the
severity of the phenotype in a Pu.1−/− background, we initially
analysed cardiac lymphatic development in mice expressing
cytotoxic diphtheria toxin A (DTA) under the control of
Cx3cr1CreER pulsed with tamoxifen at E8.5 (henceforth,
Cx3cr1CreER/+;R26R-DTA). Of note, the use of the Csf1r-CreER
line was excluded here, because this transgene does not discriminate
between bona fide EMP-derived tissue-resident macrophages and
EMP-derived LECs (Fig. 2; also see Klotz et al., 2015). At E16.5,
hearts isolated from Cx3cr1CreER/+;R26R-DTA specimens were
found to have significantly less tissue-resident macrophages in the
subepicardial compartment (control 21.51±0.720 versus mutant
15.96±1.723 LYVE1+ cells/ventricular surface area; P<0.05) and
displayed mild lymphatic vessel hyperplasia, with reduced vessel
length growth and junction number, compared with control
littermate samples (vessel length: 32,000±577.4 µm versus 28,000±
1000 µm; P<0.05; number of junctions: 148.0±5.000 versus 116.0±
5.000; P<0.05; Fig. 5A-K). Next, to enable normal cardiac seeding
by yolk sac macrophages and assess the impact of ablating these
cells at the onset of lymphatic expansion, we analysed vessel growth
and branching in mice pulsed with tamoxifen at E12.5, rather than
E8.5. The lineage tracing efficiency in Cx3cr1CreER/+ hearts using
this tamoxifen regimen was 92.5%±0.04% (tdTomato+LYVE1+/
total LYVE1+ resident macrophages; n=5 hearts), with no direct
contribution of the Cx3cr1+ lineage to LECs within the forming
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lymphatic plexus being observed (Fig. S2I-L). Moreover, in this
model, tamoxifen administration at E12.5 is anticipated to target
mostly yolk sac-derived macrophages, as CX3CR1 is not expressed
in foetal liver-derived monocytes or their precursors (Yona et al.,
2013). At E16.5, hearts isolated from Cx3cr1CreER/+;R26R-DTA
embryos pulsed with tamoxifen at E12.5 exhibited considerably less
tissue-resident macrophages in the subepicardial layer compared
with control littermate samples (control 16.72±1.945 versus mutant
6.349±0.469 LYVE1+ cells/ventricular surface area; P<0.0001;
Fig. 5L-T), and consequently lymphatic vessel growth was found to
be disrupted, with vessel length and number of junctions (i.e. vessel
branchpoints) significantly reduced (vessel length: 20,866±1088 µm
versus 17,800±734.8 µm; P<0.05; number of junctions: 240.9±26.02
versus 168.0±5.542; P<0.05; Fig. 5U,V). This phenotype, although
significant, was milder than that observed inPu.1-null hearts andmay
be explained by the efficiency of the transient ablation (tamoxifen-
induced) of macrophages in Cx3cr1CreER/+;R26R-DTA embryos, as
well as the concomitant replacement of yolk sac-derived
macrophages by foetal liver-resident, EMP-derived monocytes and
definitive HSC-derived blood-borne monocyte progenitors. This
macrophage replacement occurs throughout the time-course of
lymphatic vessel development and during this experiment
following ablation of the Cx3cr1+ lineage. The compensation by
further seeding of tissue-resident macrophages is not a factor in Pu.1
mutants, which permanently lack the entiremyeloid lineage (compare
Fig. 3F,H,P,R, devoid of any resident macrophages inPu.1-null hearts,
with Fig. 5F,H,Q,S, where there is evidence of residual or replenished
LYVE-1+ macrophages in Cx3cr1CreER/+;R26R-DTA mutant hearts).
Interestingly, genetic deletion of the Cx3cr1+ lineage resulting from
tamoxifen pulsing at either E8.5 or E12.5 also recapitulated the mis-
patterning of the main coronary veins observed in Pu.1−/− hearts
(Fig. 6A-T;white asterisks in E,G,O,Q). Collectively, these data suggest
a hitherto unidentified function for tissue-resident macrophages in
regulating the growth, patterning and expansion of the contiguous
cardiac lymphatic system.
Macrophage hyaluronan promotes lymphatic cell network
formation and sprouting
The close proximity of tissue-resident macrophages to the
developing cardiac lymphatics and evident association with the
Fig. 3. Macrophages are essential for growth and branching of the cardiac lymphatic network. (A-H) Whole-mount immunostaining for LYVE1
(green) to visualize the sub-epicardial lymphatic plexus in both the dorsal and ventral aspects of hearts derived from littermate control (co; A-D) or Pu.1−/− (E-H)
embryos at E16.5. (B,D,F,H) Magnified views of boxes shown in A,C,E,G. LYVE1 reactivity is absent in tissue-resident macrophages in Pu.1−/− hearts compared
with control littermates, confirming absence of macrophages. (I,J) Quantification of total vessel length (µm; I) and number of lymphatic vessel junctions (J) in
control versus Pu.1−/− hearts at E16.5. Data are mean±s.e.m.; n=6 hearts per group from three independent litters. Significant differences (P-values) were
calculated using an unpaired, two-tailed Student’s t-test (**P≤0.01). (K-R) Whole-mount immunostaining for LYVE1 (green) to visualize the sub-epicardial
lymphatic plexus in both the dorsal and ventral aspects of hearts derived from littermate control (co; K-N) or Pu.1−/− (O-R) embryos at E19.5. (L,N,P,R)
Magnified views of boxes shown in K,M,O,Q. (S,T) Quantification of total vessel length (µm; S) and number of lymphatic vessel junctions (T) in control
versus Pu.1−/− hearts at E19.5. Data are mean±s.e.m.; control, n=5 hearts; Pu.1−/−, n=6 hearts from four independent litters. Significant differences
(P-values) were calculated using an unpaired, two-tailed Student’s t-test (*P≤0.05; ***P≤0.001). Scale bars: 100 µm.
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forming lymphatic endothelium suggests their role in regulating
growth and patterning may be mediated by cell-cell contact at the
leading edges of fusing branches or the adventitial surface of vessel
walls (Figs 1–6). To further explore this possibility, we modelled
LEC-macrophage interactions during lymphatic capillary tube
formation and sprouting in a human in vitro setting, by co-
culturing human primary lymphatic endothelial cells and human
induced pluripotent stem cell (hiPSC)-derived macrophages
labelled with a red fluorescent protein (RFP) reporter (Fig. 7;
Movie 1). The hiPSC-derived RFP+ macrophages used here have
been previously characterized and shown to exhibit foetal-like
properties, mimicking the expression profile and function/activity
of tissue-resident macrophages (Buchrieser et al., 2017; Haenseler
et al., 2017; van Wilgenburg et al., 2013). In tube formation assays,
hiPSC-RFP+ macrophages were found in close proximity to, and
associated with LECs, changing cell shape to apparently guide LEC
extension and fusion to a neighbouring LEC, leading to vessel-like
structures (Fig. 7A-F; white arrowheads), analogous to
the behaviour we observed for embryonic macrophages in the
developing mouse heart (Fig. 1). Time-lapse live imaging revealed
this to be a highly dynamic process, with individual RFP-labelled
cells uncoupling from an individual LEC once a tube was formed
and scanning the neighbouring micro-environment for further LECs
undergoing an equivalent transformation (Movie 1). Likewise,
coincident with most of the tube-like structures becoming organized
into a plexus, hiPSC-macrophages expressing CD68 were found to
be directly associated with the forming tubes and branching nodes
(Fig. 7G-K), phenocopying the behaviour observed in vivo for
tissue-resident embryonic macrophages interacting with cardiac
lymphatics (e.g. Fig. 1Q). To model lymphatic sprouting, as an
essential first step in lymphatic growth and patterning, we employed
two independent three-dimensional (3D) assays based on co-
culturing primary human LEC-coated microbeads (hereafter
referred to as the beads assay) or aggregates of human LECs (the
spheroids assay) with iPSC-derived macrophages (Fig. 7L-X)
(Schulz et al., 2012). In the former assay, co-culturing LEC-coated
Fig. 4. Macrophages regulate coronary growth and patterning. (A-H) Whole-mount immunostaining for EMCN (red) to visualize the sub-epicardial
coronary vessels (capillaries and veins) in both the dorsal and ventral aspects of hearts derived from littermate control (co; A-D) or Pu.1−/− (E-H) embryos at
E16.5. (B,D,F,H) Magnified views of boxes shown in A,C,E,G. White asterisk indicates patterning defects, i.e. an extra mid-branch, of the coronary veins on the
dorsal aspect of Pu.1−/− hearts (compared E with A). (I,J) Quantification of total vessel length (µm; I) and number of vessel junctions (J) in control versus Pu.1−/−
hearts at E16.5. Data are mean±s.e.m.; n=6 hearts per group from three independent litters. Significant differences (P-values) were calculated using an
unpaired, two-tailed Student’s t-test (*P≤0.05; **P≤0.01). (K-R) Whole-mount immunostaining for EMCN (red) to visualize the sub-epicardial coronary vessels
(capillaries and veins) in both the dorsal and ventral aspects of hearts derived from littermate control (co; K-N) or Pu.1−/− (O-R) embryos at E19.5. (L,N,P,R)
Magnified views of boxes shown in K,M,O,Q. White asterisks indicate patterning defects, i.e. extra branches, of the coronary veins on both the dorsal and
ventral aspects of Pu.1−/− hearts (compare O,Q with K,M). (S,T) Quantification of total vessel length (µm; S) and number of vessel junctions (T) in control
versus Pu.1−/− hearts at E19.5. Data are mean±s.e.m.; control, n=5 hearts; Pu.1−/−, n=6 hearts from four independent litters. No significant differences were
determined using an unpaired, two-tailed Student’s t-test. Scale bars: 100 µm in A-D,F-H,K-R; 1 mm in E.
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microbeads with macrophages led to a significant increase in the
number of lymphatic-like sprouts per micro-bead, compared
with control culture conditions with macrophage:LEC media
alone, with RFP-expressing macrophages adjoining and in direct
contact with the sprout-leading LEC (control conditions, 100%
versus +macrophages, 173.7±12.90% sprouting activity; P<0.001;
Fig. 7L-P). A similar increase in lymphatic sproutingwas observed in
the spheroids assay (control conditions, 100% versus +macrophages,
130.9±9.387% sprouting activity; P<0.01; Fig. 7Q-X). To gain
insight into the molecular mechanism(s) underpinning stimulation of
LEC sprouting bymacrophages, we considered paracrine secretion of
VEGFC, a potent lymphangiogenic factor known to be expressed by
cardiac macrophages in a myocardial infarction setting (Vieira et al.,
2018), and cell-adhesion molecules previously implicated in
leukocyte-endothelium interactions during immune response,
specifically integrin subunit β2 (ITGB2; also known as CD18)-
and hyaluronan (HA)-dependent pathways (Gahmberg, 1997;
Jackson, 2019; Johnson et al., 2017). Although VEGFC expression
was undetectable, iPS-derived macrophages expressed both ITGB2
and ITGAM (also known as CD11b), the heterodimeric components
of the essential macrophage antigen 1 (MAC1) receptor that binds to
endothelial intracellular adhesion molecule 1 (ICAM1) during
leukocyte arrest, rolling and transmigration across the blood vessel
wall (Gahmberg, 1997). Notably, they also exhibited a dense coat of
HA (previously termed the HA glycocalyx; Johnson et al., 2017;
Lawrance et al., 2016) and expressed the HA-binding receptors
LYVE1, CD44 and HMMR (hyaluronan-mediated motility receptor;
also known as CD168) (Fig. S4A-D). To discriminate between
potential HA- and CD18-mediated adhesion to endothelium, we pre-
treated iPSC-derived macrophages with hyaluronidase (HAase), to
deplete surface glycocalyx-associated HA (Johnson et al., 2017;
Lawrance et al., 2016), or with siRNA oligonucleotides targeting
ITGB2/CD18, to specifically knockdown expression of this β-
integrin subunit without affecting the related ITGAM expression
(Fig. S4B-F). Neither treatment had a negative effect on macrophage
viability. We found that loss of macrophage ITGB2/CD18 had no
effect on sprouting activity, but macrophage pre-treatment with
HAase significantly impaired LEC sprouting in both bead and
spheroid sprouting assays (beads assay: +macrophages, 173.7±12.90
versus HAase, 96.90±7.205% sprouting activity; P<0.001; spheroids
Fig. 5. Ablation of yolk sac-derivedmacrophages impairs cardiac lymphatic growth and branching. (A-H)Whole-mount immunostaining for LYVE1 (green)
to visualize the sub-epicardial lymphatic plexus in both the dorsal and ventral aspects of E16.5 hearts-derived from littermate control (co; A-D) or Cx3cr1CreER/+;
R26R-DTA (Mut; E-H) embryos that were tamoxifen induced at E8.5. (B,D,F,H) Magnified views of boxes shown in A,C,E,G. (I-K) Quantification of LYVE1+ cells
per ventricular surface area (I), total vessel length (µm; J) and number of lymphatic vessel junctions (K) in control versus mutant hearts at E16.5. Data are mean
±s.e.m.; n=3 hearts per group from two independent litters. Significant differences (P-values) were calculated using an unpaired, two-tailed Student’s t-test
(*P≤0.05). (L-S) Whole-mount immunostaining for LYVE1 (green) to visualize the sub-epicardial lymphatic plexus in both the dorsal and ventral aspects of E16.5
hearts derived from littermate control (co; L-O) orCx3cr1CreER/+;R26R-DTA (Mut; P-S) embryos that were tamoxifen induced at E12.5. (M,O,Q,S) Magnified views
of boxes shown in L,N,P,R. (T-V) Quantification of LYVE1+ cells per ventricular surface area (T), total vessel length (µm; U) and number of lymphatic vessel
junctions (V) in control versus Mut hearts at E16.5. Data are mean±s.e.m.; control, n=8 hearts; Mut, n=7 hearts from three independent litters. Significant
differences (P-values) were calculated using an unpaired, two-tailed Student’s t-test (*P≤0.05; ****P≤0.0001). Scale bars: 100 µm.
8











assay: +macrophages, 130.9±9.387 versus HAase, 80.11±5.588%
sprouting activity; P<0.001; Fig. 7O-X), indicating a requirement for
macrophage hyaluronan in human lymphatic endothelial growth.
Importantly, yolk sac-derived macrophages residing in the HA-rich
layer of the epicardium/subepicardium compartment of the
developing mouse heart appear to lack VEGFC expression and
displayed membrane-bound HA (Fig. S5). Taken together with our
Pu.1−/− and Cx3cr1CreER/+;R26R-DTA mutant analyses (Figs 3 and
5), these findings suggest a crucial requirement for an evolutionarily-
conserved (mouse to human) HA-dependent mechanism underpinning
direct cell-cell contact/adhesion between macrophages and LECs
during vessel extension and remodelling.
DISCUSSION
Here, we reveal a novel function for macrophages residing in the
developing heart as lymphatic vessel ‘remodellers’ (Figs 1-7). Our
findings indicate that primitive macrophages migrate from the yolk
sac to the developing heart between E9.25 to E10.5 to initially
colonize the outer surface of the ventricular wall, where they reside
in the epicardium/subepicardium compartment prior to cardiac
lymphatic vessel formation. This compartment has previously been
suggested as an essential signalling axis; whereby epicardial
disruption, downstream of Wilms’ tumour 1 (Wt1) gene deficiency,
impaired cardiac recruitment of yolk sac macrophages (Stevens et al.,
2016). However, the identity of the epicardial signal(s) required for
this process has remained elusive. scRNA-seq analysis of E10.5
hearts (Fig. S1) revealed that expression of the cytokine Csf1 was
exclusively expressed in epicardial cells. CSF1 regulates the
differentiation of most macrophage populations, including primitive
yolk sac derived, and is a potent macrophage chemoattractant
(Ginhoux et al., 2010). Therefore, CSF1 is a likely mediator of
macrophage recruitment into the subepicardial region of the
developing heart. Future studies investigating the control of Csf1
activity by epicardial factors such as WT1 may provide insight into
Fig. 6. Ablation of yolk sac-derived macrophages disrupts coronary vein patterning but does not impact on vessel growth or branching. (A-H)
Whole-mount immunostaining for EMCN (red) to visualize the sub-epicardial coronary vessels (capillaries and veins) in both the dorsal and ventral
aspects of E16.5 hearts derived from littermate control (co; A-D) or Cx3cr1CreER/+;R26R-DTA (Mut; E-H) embryos that were tamoxifen induced at E8.5. (B,D,F,H)
Magnified views of boxes shown in A,C,E,G. White asterisks indicate patterning defects, i.e. an extra branch, of the coronary veins on the dorsal and
ventral aspects of Cx3cr1CreER/+;R26R-DTA hearts (compared E,G with A,C), akin to Pu.1-null hearts (compared with Fig. 4). (I,J) Quantification of total vessel
length (µm; I) and number of vessel junctions (J) in control versus mutant hearts at E16.5. Data are mean±s.e.m.; n=3 hearts per group from two independent
litters. No significant differences were determined using an unpaired, two-tailed Student’s t-test. (K-R) Whole-mount immunostaining for EMCN (red) to visualize
the sub-epicardial coronary vessels (capillaries and veins) in both the dorsal and ventral aspects of E16.5 hearts derived from littermate control (co; K-N) or
Cx3cr1CreER/+;R26R-DTA (Mut; O-R) embryos that were tamoxifen induced at E12.5. (L,N,P,R) Magnified views of boxes shown in K,M,O,Q. White
asterisks indicate patterning defects, i.e. an extra branch, of the coronary veins on the dorsal and ventral aspects ofCx3cr1CreER/+;R26R-DTA hearts (compare O,
Q with K,M), akin to Pu.1-null hearts (compared with Fig. 4). (S,T) Quantification of total vessel length (µm; S) and number of vessel junctions (T) in control
versus mutant hearts at E16.5. Data are mean±s.e.m.; control, n=8 hearts; mutant, n=7 hearts from three independent litters. No significant differences were
determined using an unpaired, two-tailed Student’s t-test. Scale bars: 100 µm.
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the molecular basis leading to cardiac seeding by yolk sac-derived
macrophages.
The epicardium plays an essential role during heart development
by secreting paracrine signals stimulating cardiomyocyte
proliferation and maturation, as well as supporting cardiac
vasculature expansion (Simões and Riley, 2018). Within the
subepicardial space, tissue-resident macrophages co-exist with
both coronary and lymphatic endothelium. Our study attributes
novel function to these resident macrophages in regulating the onset
of cardiac lymphatic growth and patterning, along the base-apex
axis and laterally to cover both dorsal and ventral surfaces of the
developing heart. Tissue-resident macrophages were observed
proximal and in direct contact with lymphatic vessels, where they
accumulated at branch points. Moreover, in two independent mutant
mouse models, Pu.1−/− andCx3cr1CreER/+;R26R-DTA, macrophage
depletion resulted in a truncated and mis-patterned lymphatic
Fig. 7. Macrophages promote lymphatic cell plexus formation and sprouting. (A-F) Representative frames of time-lapse experiments using primary human
lymphatic endothelial cells (hLECs; phase-contrast) co-cultured with human iPS-derived macrophages labelled with RFP (red), showing close association
between macrophages and LECs, and a change in macrophage cell morphology (white arrowheads) contacting the expanding lymphatic plexus to facilitate
LEC tube formation. (G-K) DAPI (blue), CD68 (green) and phalloidin (red) staining of primary hLEC and hiPSC-macrophage co-cultures. (K) Magnified view
of box shown in J. Arrowheads indicate macrophages. (L-N) Representative staining of lymphatic capillary sprouting from beads coated with primary hLECs only
(green; control medium; L) or co-cultured with hiPSC-derived macrophages-RFP (red; +macrophages; M). (N) Magnified view of the box shown in M. Arrows and
arrowheads indicate lymphatic sprouts and macrophages, respectively. (O,P) Quantification of the percentage sprouting activity defined as (number capillary
sprouts/number of beads)×100. Data are normalized against the control group. Data are mean±s.e.m.; control, n=6; +macrophages, n=6; HAase 30 U/ml,
n=3; siControl, n=3; siCD18 #1, n=3; siCD18 #2, n=3 independent experiments, with three replicates/experiment. Significant differences (P-values) were
calculated using one-way ANOVA followed by Tukey’s multiple comparison test (***P≤0.001). (Q-V) Representative staining of lymphatic capillary sprouting from
hLECs aggregates/spheroids only (green; control medium; Q) or co-cultured with hiPSC-derived macrophages-RFP (red; +macrophages; R,T); and of
hiPSC-derived macrophages-RFP pre-treated with HAase 30 U/ml (S) or co-cultured with hiPSC-derived macrophages-RFP pre-treated with siRNA
oligonucleotides against ITGB2/CD18 (siCD18 #1, U; siCD18 #2, V). (W,X) Quantification of the percentage of sprouting activity defined as (number capillary
sprouts/number of beads)×100. Data were normalized against the control group. Data are mean±s.e.m.; control, n=5; +macrophages, n=4; HAase 30 U/ml, n=4;
siControl, n=3; siCD18 #1, n=3; siCD18 #2, n=3 independent experiments, with three replicates/experiment. Significant differences (P-values) were calculated
using one-way ANOVA followed by Tukey’s multiple comparison test (**P≤0.01; ***P≤0.001). Scale bars: 100 µm in A-M,R-V; 50 µm in N; 250 µm in Q.
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plexus, suggesting an essential role in modulating the extension and
branching of the lymphatic endothelium (Figs 3 and 5). With
regards to non-yolk sac-derived macrophages (i.e. foetal liver),
these only colonize the developing heart at a timepoint when the
cardiac lymphatic network is already well-established (from E14.5
onwards), and, therefore, we can discount these cells from being
relevant for the onset of cardiac lymphatic expansion, but we cannot
rule out a role at later developmental stages (e.g. maintenance versus
remodelling of the vascular network).
A previous study reported an analogous role for embryonic
macrophages in the remodelling of the primitive coronary blood
plexus (Leid et al., 2016). Here, the authors revealed that resident
macrophages control the selective expansion of perfused blood
vessels, and that an absence of macrophages resulted in hyper-
branching of the developing coronaries (Leid et al., 2016). In
contrast, we observed a transient reduction in vessel growth and
branching (Fig. 4), and a mild, but reproducible, mis-patterning of
the coronary vessels following macrophage depletion in Pu.1−/−
and Cx3cr1CreER/+;R26R-DTA mutant mice (Figs 4 and 6). Our
findings are supported by studies documenting reduced vessel
branching in alternative vascular beds of mice lacking embryonic
macrophages, such as the developing hindbrain and postnatal retina
(Fantin et al., 2010). Thus, the differences in severity of phenotype
between our analyses and those of Leid and colleagues could be due
to distinct mouse models used and/or approaches employed to
characterize the coronary vasculature [whole-mount heart
immunostaining in this study versus analyses of cryosections in
previous work (Leid et al., 2016)].
At a molecular level, the remodelling of the lymphatic
vasculature could arise from macrophage phagocytic activity,
release of soluble cytokines or cell-cell interactions. Tissue-
resident macrophages have been reported to control various
processes during vessel development, in a variety of blood and
lymphatic vascular beds, mediated by secretion of trophic factors.
These include regression of the transient hyaloid endothelium by
inducing WNT7B-driven cell death (Lobov et al., 2005), inhibition
of branch formation in the developing lymphatic system in the
diaphragm through secretion of an elusive factor (Ochsenbein et al.,
2016), controlling LEC proliferation in dermal lymphatics (Gordon
et al., 2010) and mediating coronary blood plexus remodelling
through selective expansion of the perfused vasculature via insulin-
like growth factor (IGF) signalling (Leid et al., 2016). In contrast,
our findings in the developing mouse heart and in vitro models of
human lymphatic capillary tube formation and sprouting (Figs 3, 5
and 7) favour a mechanism mediated by direct macrophage-
endothelial cell physical contact/adhesion (Fig. 1), similar to the
role of macrophages in the developing hindbrain and retinal
vasculature (Fantin et al., 2010). In this regard, a requirement for
macrophage HA in lymphatic sprouting was identified (Fig. 7). HA
is a key structural component of the vertebrate extracellular matrix
and has recently been implicated in the postnatal development and
response to adult injury (inflammation driven) of murine corneal
lymphangiogenesis (Sun et al., 2019), a process that also depends
on the presence of macrophages (Maruyama et al., 2012).
Hyaluronan levels are determined, partly by three hyaluronan
synthases (HAS1-HA3) and three hyaluronidases (HYAL1-
HYAL3) (Triggs-Raine and Natowicz, 2015). HA is also known
to interact with different cell surface receptors, including LYVE1,
CD44 and HMMR/CD168, to directly influence endothelial cell
motility, proliferation and survival, although the role of such
receptors in the regulation of hyaluronan levels remains elusive
(Savani et al., 2001; Triggs-Raine and Natowicz, 2015). As such,
functional redundancy of different HA-binding proteins likely
contributes to the lack of a developmental (lymphatic) phenotype in
Lyve1 and Cd44 single and compound knockout mice (Gale et al.,
2007; Luong et al., 2009). Conversely, genetic disruption of
hyaluronan synthesis either abrogated normal cardiac
morphogenesis, leading to mid-gestation lethality, or impaired the
response of cardiac macrophages to ischemia reperfusion injury,
resulting in poor macrophage survival and functional cardiac output
(Camenisch et al., 2000; Petz et al., 2019). Thus, further studies are
needed to dissect out the HA/HA-binding receptor axis required for
macrophage-induced lymphatic sprouting. In particular, it will be
important to investigate the requirement for HA-mediated signalling
in macrophages residing in the subepicardial compartment during
the early stages of cardiac lymphatic growth. Likewise, an indirect
effect, via the release of a soluble growth factor(s) by tissue-resident
macrophages cannot be categorically ruled out at this stage, albeit
we can discount VEGFC given its undetectable expression by
macrophages in the developing heart (Fig. S5). In addition, future
studies investigating subepicardial resident-macrophages should
focus on expanding the phenotypic characterization of these cells,
e.g. via the use of unbiased single cell RNA-sequencing (scRNA-
seq) platforms followed by careful examination/validation in situ
(mapped against lymphatic expansion) and selective cell targeting
(based on their marker profile).
We assign a novel function to the yolk sac-derived tissue-resident
macrophage lineage, against a back-drop of a rapidly evolving field
that attributes ever increasing plasticity, in terms of cell fate and
signalling, to these essential resident lineages. This is
complemented by insights into our fundamental understanding of
how discrete organ-based vascular beds are formed and the degree
of heterogeneity in terms of cellular contributions to organ-specific
endothelium. Live imaging in the adult mouse and zebrafish has
demonstrated that inflammatory macrophages are required for
orchestration of skin wound neoangiogenesis (Gurevich et al.,
2018). Likewise, macrophages of diverse phenotypes support
vascularization of 3D human engineered tissues (Graney et al.,
2020). Moreover, the maintenance of the mouse choroidal vascular
network, as well as lymphatic vessels in the cornea, is dependent on
the presence of macrophages, with decreased macrophage number
and activation leading to reduced lymphatic vessel formation and
contributing to impaired diabetic wound healing in a mouse model
of corneal wound healing (Maruyama et al., 2007, 2012; Yang et al.,
2020). Importantly, the close interaction between cardiac
lymphatics and macrophages during development also appears to
manifest in the postnatal heart via infiltrating inflammatory
macrophages and injury-activated lymphangiogenesis following
myocardial infarction (Klotz et al., 2015; Vieira et al., 2018). The
functional role for macrophages in directly regulating lymphatic
growth and remodelling during development we report herein may,
therefore, manifest in response to injury in the adult setting. Taken
together, this further strengthens the rationale for extrapolating our
developmental studies to therapeutically target macrophage-
lymphatic responses during postnatal cardiovascular disease/injury.
MATERIAL AND METHODS
Mouse lines
Genetically modified mouse lines used in the study were kept in a pure
C57BL/6 genetic background and are listed in Table S1. Cx3cr1GFP knock-
in mice and hCD68-GFP transgenic mice were crossed with C57BL/6 to
generate Cx3cr1GFP/+ and hCD68-GFP+ samples, respectively. Pu.1+/−
mice were intercrossed to generate Pu.1−/− specimens. Csf1r-CreER
transgenic mice, Cx3cr1CreER/+ knock-in mice and Flt3CreERT2/+ mice
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were crossed with R26R-tdTomato or R26R-DTA reporter strains to generate
Csf1r-CreER;tdTomato, Cx3cr1CreER/+;R26R-tdTomato, Cx3cr1CreER/+;
R26R-DTA and Flt3CreERT2/+;tdTomato mice. Both males and females
were used in the study. For timed-mating experiments, 8- to 16-week-old
mice were set up overnight and females checked for vaginal plugs the
following morning; the date of a vaginal plug was set as embryonic day (E)
0.5. For tamoxifen-dependent tissue-specific gene activation, a 75 mg/kg
dose of tamoxifen (Sigma-Aldrich) was administered to pregnant dams,
intraperitoneally. Mice were housed and maintained in a controlled
environment by the University of Oxford Biomedical Services. All animal
experiments were carried out according to the UK Home Office project
license (PPL) 30/3155 and PPDE89C84 compliant with the UK animals
(Scientific Procedures) Act 1986 and approved by the local Biological
Services Ethical Review Process.
Cell lines
Primary human dermal lymphatic endothelial cells (HDLEC) isolated from
the dermis of juvenile foreskin (PromoCell) were cultured in the presence of
endothelial cell growth medium (ECGM)-MV2 (PromoCell), according to the
manufacturer’ instructions. Human iPS-derived macrophages constitutively
expressing RFP (Haenseler et al., 2017) were obtained from the James Martin
Stem Cell Facility (Sir William Dunn School of Pathology, University of
Oxford, UK). The human iPS cell line was derived previously from dermal
fibroblasts of a healthy donor that had given signed informed consent for the
derivation of iPS cells [Ethics Committee: National Health Service, Health
Research Authority, NRES Committee South Central, Berkshire, UK (REC
10/H0505/71)]. iPS-macrophages were cultured in macrophage medium
composed of X-VIVO 15 (Lonza), GlutaMax (Invitrogen) and M-CSF
(Invitrogen), as previously described (van Wilgenburg et al., 2013). Cell lines
were maintained in a humidified atmosphere of 5% CO2 at 37°C. Of note,
results arising from co-cultures of human LECs (HDLECs) and iPS-derived
macrophages expressing RFP (Fig. 7) were validated by using the alternative
primary human dermal microvascular endothelial cells (HMVEC-dAD),
derived from an adult donor (Lonza), and human wild-type (WT)
macrophages (no reporter) obtained from the James Martin Stem Cell
Facility (Sir William Dunn School of Pathology, University of Oxford, UK).
The latter were derived from the human iPS cell line SFC856-03-04.
Sample preparation for immunostaining
Embryos were harvested at the required embryonic stage, placed in ice-cold
PBS (Sigma-Aldrich) and the amniotic sac was removed. The heart was
micro-dissected from the embryo for immunostaining experiments using
fine forceps. Dissected hearts were fixed for 6 h in 2% PFA/PBS at room
temperature, permeabilized in 0.3% Triton X-100/PBS (twice, 10 min each)
and then blocked in 1% BSA, 0.3% Triton X-100 in PBS for at least 2 h.
Samples from fluorescent reporter lines (e.g. Cx3cr1GFP and CD68-GFP)
were protected from light throughout this procedure. Samples were
incubated with primary antibodies (diluted in block; listed in Table S1)
overnight at 4°C, then washed three times for at least 1 h each in 0.3% Triton
X-100/PBS. Samples were incubated with Alexa Fluor-conjugated
secondary antibodies (diluted in PBS; Invitrogen) overnight at 4°C,
protected from light, then rinsed three times for at least 10 min each with
PBS. The hearts were then orientated according to dorsal-ventral surface
aspect and mounted in 50% glycerol/PBS in glass-bottomed dishes
(Mattek). Imaging was performed using an Olympus FV 1000 or Zeiss
LSM 780 scanning confocal microscope. Tiled images were acquired using
a 10× objective to include an overview of whole hearts and at least three
different fields were captured at higher magnification (20× objective) per
heart surface aspect (dorsal vs ventral) per sample. Images were digitally
captured and processed using Zen and FIJI-ImageJ software. Analysis of
total vessel length and junction number calculation were performed using
AngioTool software that enables automated assessment of the entire
vascular network covering the subepicardial surface (Zudaire et al., 2011).
Briefly, the quantitative analyses of vascular networks (lymphatic and blood
vessels) were carried out by tracing vessels only using ImageJ and then
analysing the traced networks on AngioTool. Of note, throughout this study
the cardiac lymphatic vasculature was labelled using (at least) dual
combinations of antibodies against LECs, such as LYVE-1/VEGFR3 or
LYVE-1/PROX1. This strategy allowed combination with a third antibody
to label coronary vessels (e.g. EMCN), thereby maximizing the information
extracted/sample and, more importantly, excluding a possible bias when
tracing the vessels arising from LYVE-1 labelling of both lymphatic
endothelium and tissue-resident macrophages. At least two independent
litters and three embryos were used to generate the data discussed here, with
representative images being shown in main figures and supplementary
figures.
Preparation of single cell suspensions from the heart
Foetal hearts harvested for flow cytometry studies were isolated, placed in
ice-cold HBSS (Life Technologies), finely minced into small pieces and
digested with collagenase type II (Worthington Laboratories) solution
(containing 500 units/ml HBSS) at 37°C for 30 min with agitation at
180 rpm. Dissociated samples were then passed into a 50 ml conical tube
(Corning) through a 70 µm cell strainer, then rinsed with 3 ml ice-cold
HBSS and transferred back to a 15 ml conical tube. Samples were spun for
7 min at 350 g at 4°C, and the supernatant carefully discarded. Cell pellets
were resuspended in 5 ml of red blood cell (RBC) lysis buffer (BioLegend)
and incubated at room temperature for 10 min, followed by a repeat
centrifugation at 350 g at 4°C for 7 min. The RBC lysis buffer was removed
and cells were resuspended in 2% FBS/PBS. Isolated single cardiac cells
were stained and subjected to flow cytometry analyses.
Flow cytometry
Using 7-AAD exclusion (BD Pharmingen), only live cells were analysed.
All antibodies used for flow cytometry are listed in Table S1. Flow
cytometric analyses were performed using FACSAria III flow cytometer
(BD Biosciences) and FlowJo software (LLC). Samples resuspended in 2%
FBS/PBS solution were blocked with mouse Fc Block (Miltenyi Biotec) for
5 min on ice, followed by labelling for 20 min at room temperature with
each antibody combination.
Time-lapse tube formation assay
384-well plates (PerkinElmer) were coated with growth factor-reduced
Matrigel (Corning) and incubated for 30 min at 37°C. ECGM-MV2
containing 4500 HDLECs (25 μl per well) was added and incubated for
60 min at 37°C. Macrophage media containing 2250 human iPS-derived
macrophages-RFP was then added (25 μl per well). For time-lapse imaging
acquisition, an Evos FL Auto Cell Imaging System (Thermo Fisher Scientific)
was used and one image was taken every 8 min for 15 h. At the end of image
acquisition, cells were fixedwith 4%PFA solution (Santa Cruz Biotechnology)
for 30 min and washed with PBS for further analysis (e.g. immunostaining).
Immunostaining of HDLEC-macrophage co-cultures
HDLEC-like tubes were permeabilized with 0.1% Triton X-100/PBS and
then incubated with a staining solution containing Alexa Fluor 568
Phalloidin and DAPI (both Invitrogen). Immunofluorescence staining was
performed using an antibody against human CD68 (Abcam; see Table S1).
iPS-derived macrophage transfection
Macrophages were transfected in a 24-well plate as previously described
(Troegeler et al., 2014). Macrophages were washed twice with warm
complete XVIVO in order to remove floating cells. Fresh complete XVIVO
was added (250 μl per well) and cells kept at 37°C and 5% CO2. siRNA
(3.75 μl of 20 μM; Thermo Fisher Scientific), 110.25 μl XVIVO depleted
(without MCSF) and 11 μl HiPerfect (Qiagen) were gently mixed in a tube
and incubated at room temperature for 15-20 min. 125 μl of the mix was
then added in each well drop by drop. The plate was gently rocked to ensure
even distribution of the mix. After 6 h, 0.5 ml of Complete XVIVO was
added and the cells were harvested 3 days later for RNA extraction and/or
experimental procedures.
HAase treatment and immunostaining
Macrophages were seeded on coverslips and treated with 15 U/ml or
30 U/ml hyaluronidase (HAase; Sigma-Aldrich) 2 h before the experiment.
For staining, cells were fixed with 4% PFA and permeabilized in 0.2%
Triton X-100/PBS for 10 min and then blocked in 1% BSA, 0.1% Triton
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X-100 in PBS for at least 2 h. Macrophages were incubated with 3 μg/ml
biotinylated hyaluronan-binding protein (Amsbio) overnight at 4°C, then
washed three times with PBS. Samples were incubated with Alexa Fluor 488
Streptavidin (diluted in PBS; Biolegend) overnight at 4°C, protected from
light, then rinsed three times for at least 10 min each with PBS. Coverslip
were thenmounted on slides using Vectashield+DAPI (Vector Laboratories).
Microbeads capillary sprouting assay
The capillary sprouting assay was performed as previously described
previously (Schulz et al., 2012). HDLECs were incubated in a 15 ml conical
tube in presence of cytodex 3 beads (Sigma-Aldrich) at a ratio of 400 cells
per bead in EGM-2MVmedium (Lonza) for 4 h at 37°C with shaking every
20 min. Beads were then incubated in a cell flask at 37°C for 48 h in EGM-
2MV medium. The HDLEC-coated beads were subsequently collected and
labelled with 2 μM Cell Tracker Green dye (Invitrogen) for 30 min,
embedded in 1 mg/ml Type I collagen hydrogel (Advanced Bio-Matrix)
containing 2 μMD-erythro-sphingosine-1-phosphate (Avanti Polar Lipids),
and cultured in black clear-bottom 96-well plates (Perkin-Elmer) in the
presence or absence of 10,000 human iPS-derived macrophages-RFP per
well. After 60 min of incubation, a 1:1 mix containing EGM2-Incomplete
(EGM2 media without supplementation with EGF, FGF2 and VEGF-A;
Lonza) and macrophage media (v/v) was added and the beads incubated for
2 days at 37°C. The beads were then fixed with 4% PFA for 30 min and
washed twice with PBS. Each well was imaged with a Zeiss LSM 780
scanning confocal microscope and the number of sprouts per bead
calculated.
Spheroids sprouting assay
Spheroids of 400 HDLECs were generated using a 24-well plate Aggrewell
400 (Stemcells Technologies) using EGM2-Incomplete. The following day,
spheroids were collected and embedded in 1 mg/ml Type I collagen
hydrogel and cultured in black clear-bottom 384-well plates (Perkin-Elmer)
in the presence or absence of 2500 human iPS-derived macrophages-RFP
per well. After 60 min of incubation, a 1:1 mix containing EGM2-
Incomplete (Lonza) and macrophage media (v/v) was added, and the
spheroids incubated for 2 days at 37°C. The spheroids were then fixed with
2% PFA for 30 min, washed twice with PBS and stained with Alexa Fluor
488 phalloidin (Invitrogen). Each well was imaged with an automated cell
imaging system (Pico microscope, Molecular Devices) and the number of
sprouts per spheroids calculated.
RNA extraction and qRT-PCR
Total RNA was extracted using Trizol Reagent (Invitrogen). Reverse-
transcription (RT) was performed using SuperScript(R) III Reverse
Transcriptase (Invitrogen), as recommended by the manufacturer. Primer
sequences (Invitrogen) used were: 36B4_F, CTACAACCCTGAAGAAG-
TGCTTG; 36B4_R, CAATCTGCAGACAGACACTGG; CSF1R_F, CCT-
CACTGGACCCTGTACTC; CSF1R_R, GGAAGGTAGCGTTGTT-
GGTG; CX3CR1_F, ACCAACTCTTGCAGGTCTC; CX3CR1_R, TGTC-
AGCACCACAACTTGG; ITGB2/CD18_F, GTCTTCCTGGATCACAAC-
GC; ITGB2/CD18_R, CAAACGACTGCTCCTGGATG; ITGAM/
CD11b_F, CAGTGAGAAATCCCGCCAAG; ITGAM/CD11b_R, CCGA-
AGCTGGTTCTGAATGG; VEGFC_F, GGAGGCTGGCAACATAACA-
G; VEGFC_R, TTTGTCGCGACTCCAAACTC; LYVE1_F, CTGGGTT-
GGAGATGGATTCG; LYVE1_R, TCAGGACACCCACCCCATTT; C-
D44_F, AAGTGGACTCAACGGAGAGG; CD44_R, GTCCACATTCT-
GCAGGTTCC; HMMR/CD168_F, GGCTAAGCAAGAAGGCATGG;
and HMMR/CD168_R, TCCCTCCAGTTGGGCTATTT.
Real-time polymerase chain reaction (PCR) assays were run on a ViiA 7
step real-time PCR machine (Applied-Biosystems). Normalization was
performed using 36B4 as a reference gene. Quantification was performed
using the comparative Ct method.
scRNA-seq and analysis
E7.75_E8.25_E9.25 10x Chromium data (GSE126128) were downloaded
from UCSC Cell Browser as raw UMI count matrix (de Soysa et al., 2019).
Only the E9.25 datasets were selected for further analysis. E10.5 heart 10x
Chromium data were downloaded as raw counts from GEO (GSE131181)
(Hill et al., 2019). All scRNA-seq datasets were analysed using Seurat
(Butler et al., 2018; Stuart et al., 2019) in R as follows: individual replicates
were integrated using SCTransform method; principal component analysis
was used to define the cell clusters, which were visualized with the UMAP
method (Becht et al., 2018; Butler et al., 2018).
Statistical analysis
All data are presented as mean±s.e.m. Statistical analysis was performed on
GraphPad Prism 8 software. The statistical significance between two groups
was determined using an unpaired two-tailed Student’s t-test; these included
a F-test to confirm the two groups had equal variances. Among three or
more groups (e.g. data shown in Fig. 1A), one-way analysis of variance
(ANOVA) followed up by Tukey’s multiple comparison test was used for
comparisons. P≤0.05 was considered statistically significant.
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